GlassScriptPhysician profile
Marcus Paul Schmitz
NPI 1821071895
$3,206.10
in general payments reported to CMS, 2019-2025
14 companies · $584 in 2025
The $584 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $648 · 2020: $264 · 2021: $311 · 2022: $364 · 2023: $883 · 2024: $152 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,619.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spine Wave, INC. | $1,132.70 | 2019-2025 | Spinal Implant, Annex Adjacent Level System |
| Medtronic, INC. | $901.16 | 2022-2025 | Intellis Adaptivestim, Mazor X System, Unid_pass |
| Nevro Corp. | $510.28 | 2019-2023 | Senza |
| Stryker Corporation | $235.60 | 2022-2025 | Nico Brainpath, Nico Myriad, Universal Neuro 3 |
| Boston Scientific Corporation | $232.35 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Insightec,INC | $45.34 | 2023 | Exablate |
| Arbor Pharmaceuticals, INC. | $27.04 | 2019 | |
| Convatec INC. | $24.28 | 2025 | |
| Mml US, INC. | $19.84 | 2023 | Reactiv8 |
| Cerapedics INC. | $19.67 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Orthofix Medical, INC. | $19.13 | 2022 | |
| Depuy Synthes Sales INC. | $14.85 | 2023 | Synthecel |
| Next Science LLC | $14.51 | 2023 | Xperience, Blastx, Surgx |
| Brainlab, INC. | $9.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Schmitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.